Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on September 9, 2025 to shareholders of record at the close of business on August 26, 2025. The ex-dividend date is August 26, 2025.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250715350667/en/

Media:
[email protected]

Investors:
[email protected]

Source: Johnson & Johnson

You May Also Be Interested In

• Workato Opens National Office and Data Center in South Korea to Support Customers and Partners in AI Adoption
• Association of Black Cardiologists Names 2026 Spirit of the Heart Honorees
• Milhaus Completes Acquisition of Broadshore Capital Partners